News
The U.S. Food and Drug Administration has approved the Sonu Band, an artificial intelligence-enabled, wearable medical device ...
4d
Pharmaceutical Technology on MSNMosanna Therapeutics gains $80m to advance OSA nasal sprayThe new funding will support MOS118 through its Phase II development while expanding Mosanna's product pipeline.
Mosanna Therapeutics announced today that it closed an $80 million Series A funding to support its sleep apnea therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results